Skip to main content

Table 1 Baseline characteristics n = 247

From: Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

Parameter Number Percent
Age
 Median (range) 52 (28–78)  
Menopausal Status
 Premenopausal 111 44.9
 Perimenopausal 5 2.0
 Postmenopausal 126 51.0
 Unknown 5 2.0
Tumor Size
 cT 1 14 5.7
 cT 2 123 49.8
 cT 3 68 27.5
 cT 4 27 10.9
 Unknown 15 6.1
Histology
 ILC 27 10.9
 IDC 194 78.5
 Mixed 21 8.5
 Others 2 0.8
 Unknown 3 1.2
Tumor Grading
 G1 17 6.9
 G2 86 34.8
 G3 122 49.4
 Unknown 22 8.9
Her2 Status
 Negative 164 66.4
 Positive 49 19.8
 Unknown 34 13.8
ER Status
 Negative 95 38.5
 Positive 150 60.7
 Unknown 2 0.8
PR Status
 Negative 106 42.9
 Positive 134 54.3
 Unknown 7 2.8
Lymph node Status
 Negative 98 39.7
 Positive 147 59.5
 Unknown 2 0.8
Neoadjuvant Therapy
 Anthracycline 81 32.8
 Anthracycline/Taxane 144 58.3
 Taxane 7 2.8
 Others 15 6.1
No of therapy cycles
 Median (range) 4 (1–8)  
Response to Therapy
 No (Sinn 0) 75 30.4
 Yes (Sinn 1–4) 172 69.6
pCR
 No (Sinn Score 0,1,2) 218 88.3
 Yes (Sinn Score 3,4) 29 11.7
pCR
 No (all others) 216 87.4
 Yes (Sinn 3 or 4 and pN0) 21 8.5
 Unknown 10 4.0
Recurrence
 No 150 60.7
 Yes 95 38.5
 Unknown 2 0.8
  1. Abbreviation: pCR pathologic complete remission